Featured
-
Vanderbilt School of Medicine Basic Sciences welcomes the next generation of biomedical scientists
The Vanderbilt University School of Medicine Basic Sciences welcomed 42 new graduate students into its Interdisciplinary Graduate Program and Quantitative and Chemical Biology Program through orientation events and the Simple Beginnings ceremony. These academic programs combine coursework and research to guide students toward earning a Ph.D. and careers in the biomedical sciences. Read MoreSep. 25, 2025
-
NCI grant funds $12 million for colorectal cancer research
A colorectal cancer research team led by Robert Coffey has received a Specialized Programs of Research Excellence grant renewal totaling $12.6 million from the National Cancer Institute.The team has made numerous discoveries over the past 23 years, and it plans to build upon those achievements with the goal of “drugging the undruggable.” Vanderbilt-Ingram is one of only four cancer centers in the U.S. with GI Cancer SPORE funding. Read MoreSep. 15, 2025
-
Cortez, Bhowmick win Chancellor’s Award for Research at 2025 Fall Faculty Assembly
David Cortez and Rahul Bhowmick won the Chancellor’s Award for Research for their work, “RAD51 Bypasses the CMG Helicase to Promote Replication Fork Reversal,” which was published in the journal Science. Read MoreSep. 5, 2025
-
Hayes, Nagarajan, and Costanzo win 2025 Cell Imaging Shared Resource Life Is Beautiful Image Contest
James Hayes, Rekha Nagarajan, and James Costanzo are the winners of the 2025 Cell Imaging Shared Resource Life Is Beautiful image contest. CISR provides researchers with access to state-of-the-art imaging equipment and expert technical support for sophisticated microscopy and analysis of tissue and cellular anatomy and physiology. Read MoreAug. 7, 2025
-
Scott Hiebert named Chief Scientific Officer of Cancer Prevention and Research Institute of Texas
Scott Hiebert, Hortense B. Ingram Chair in Cancer Research, has been named Chief Scientific Officer of the Cancer Prevention and Research Institute of Texas. Hiebert served as chair of the National Cancer Advisory Board and brought global recognition to the Vanderbilt-Ingram Cancer Center during his 28 years at Vanderbilt. Read MoreAug. 4, 2025
-
Kidney atlas maps molecular landscape, unlocking clues to renal health and disease
In a landmark study published in Science Advances, Vanderbilt researchers have created the first high-resolution lipid atlas of the human kidney, mapping over 100,000 functional tissue units across 29 donors. By integrating advanced imaging mass spectrometry with microscopy using machine learning, the team identified distinct lipid signatures that could transform diagnostics and precision treatments for kidney disease. Read MoreJun. 17, 2025
-
MALDI magic: AIMS empowers scientists through transformative learning
Just as swallows journey to San Juan Capistrano, California, and monarch butterflies migrate to Michoacan, Mexico, each spring, so mass spectrometrists from across the globe converge on Vanderbilt University for the annual, four-day Advanced Imaging Mass Spectrometry workshop. Read MoreJun. 10, 2025
-
2025 School of Medicine Basic Sciences Dean’s Award for Exceptional Achievement in Graduate Studies winners announced
The School of Medicine Basic Sciences is proud to announce the 2025 recipients of the Dean’s Award for Exceptional Achievement in Graduate Studies. Ten graduate students were recognized for their high academic and scientific achievement and for the originality, significance, and rigor of their dissertation research. Read MoreJun. 10, 2025
-
Traveling westward: ASPIRE on the Road visits San Diego
Vanderbilt biomedical graduate students and postdocs attended ASPIRE on the Road 2025 in San Diego, California. Over three days, they explored Southern California's biotech and pharmaceutical scene, connecting with alums, industry leaders, and innovative companies. Read MoreJun. 5, 2025
-
New Warren Center TREK channel compounds reveal power of academic-industry partnerships in drug discovery
What makes these results exceptional isn’t just the compounds themselves, it’s what they represent: the value of translational research grounded in real-world therapeutic goals. The partners chose to release these best-in-class tool compounds to the scientific community to accelerate further discovery. Read MoreJun. 5, 2025